Intrinsic Value of S&P & Nasdaq Contact Us

Legend Biotech Corporation LEGN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
58/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$58.60
+213.5%

There have been 13 recent insider transactions recorded for Legend Biotech Corporation (LEGN), including 0 buys and 1 sell. Total insider buying was valued at RSU Award and total insider selling at $87.14K.

Notable insiders with recent activity include Huang Ying, Sanders Corazon (corsee) D., Heyman Tomas J.. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — LEGN

Date Name Role Transaction Shares Avg. Price Value Shares Owned
2026-03-25 Huang Ying Chief Executive Officer Informative Sell 9,936 $8.77 $87.14K 247,438
2026-03-18 Sanders Corazon (corsee) D. Director Unknown 12,000 $11.50 $138K -
2026-03-18 Heyman Tomas J. Director Unknown 30,000 $23.27 $698.1K -
2026-03-18 Zhang Fangliang Officer Unknown - - - -
2026-03-18 Huang Ying Chief Executive Officer Unknown 92,134 $14.12 $1.3M -
2026-03-18 Ji Darren Xiaohui Director Unknown 30,000 $11.50 $345K -
2026-03-18 Casey Patrick John Director Unknown 30,000 $14.12 $423.6K -
2026-03-18 Salovey Peter Director Unknown - - - 26,766
2026-03-18 Santos Carlos E Officer Unknown - - - -
2026-03-18 Mao Li Director Unknown 30,000 $23.27 $698.1K -
2026-03-18 Wang Ye Director Unknown - - - 16
2026-03-18 Meng Robin Officer Unknown - - - -
2026-03-18 Kung Gareth Director Unknown - - - 31,486
Informative Buy/Sell — open market transaction (most significant) Uninformative Buy — award, option exercise, conversion Uninformative Sell — tax withholding, award vest sale Neutral — gift, trust, expiry
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message